Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Healthcare (NHC) Other financing activities (2016 - 2025)

Historic Other financing activities for National Healthcare (NHC) over the last 17 years, with Q3 2025 value amounting to $20000.0.

  • National Healthcare's Other financing activities fell 9895.23% to $20000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$210000.0, marking a year-over-year decrease of 11156.39%. This contributed to the annual value of $1.1 million for FY2024, which is 55976.33% up from last year.
  • Per National Healthcare's latest filing, its Other financing activities stood at $20000.0 for Q3 2025, which was down 9895.23% from -$127000.0 recorded in Q2 2025.
  • In the past 5 years, National Healthcare's Other financing activities ranged from a high of $1.9 million in Q3 2024 and a low of -$914000.0 during Q1 2022
  • For the 5-year period, National Healthcare's Other financing activities averaged around -$22105.3, with its median value being -$127000.0 (2025).
  • Its Other financing activities has fluctuated over the past 5 years, first crashed by 61406.25% in 2022, then soared by 108611.11% in 2023.
  • Over the past 5 years, National Healthcare's Other financing activities (Quarter) stood at -$370000.0 in 2021, then skyrocketed by 109.73% to $36000.0 in 2022, then soared by 1086.11% to $427000.0 in 2023, then tumbled by 164.17% to -$274000.0 in 2024, then soared by 107.3% to $20000.0 in 2025.
  • Its Other financing activities was $20000.0 in Q3 2025, compared to -$127000.0 in Q2 2025 and $171000.0 in Q1 2025.